Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
278 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06885333 | Whole-Brain Tumor Burden Metrics with Inflammatory and Molecular Markers to Predict Postoperative Neurocognitive Decline in Glioma | completed | — | 192 | West China HospitalOTHER | 0 | Mar 20, 2025 | clinicaltrials |
| NCT05920980 | Effect of Lidocaine on Postoperative Pain in Elderlypatients Undergoing Colorectal Cancer Surgery | completed | N/A | 276 | West China HospitalOTHER | 1 | Feb 19, 2025 | clinicaltrials |
| NCT06810349 | Predicting Tumor Origin Based on Deep Learning of Lymph Node Puncture Cytology | recruiting | — | 10,000 | West China HospitalOTHER | 1 | Feb 5, 2025 | clinicaltrials |
| NCT06804863 | Regret Emotion After Thyroidectomy in Low-Risk Papillary Thyroid Cancer | not yet recruiting | N/A | 600 | West China HospitalOTHER | 1 | Feb 3, 2025 | clinicaltrials |
| NCT06800482 | A Study of Online Follow-up in Patients With Papillary Thyroid Cancer | recruiting | N/A | 388 | West China HospitalOTHER | 1 | Jan 30, 2025 | clinicaltrials |
| NCT06779539 | Neoadjuvant Ensartinib in ALK Positive Resectable Stage II to III Non-Small Cell Lung Cancer | not yet recruiting | Phase 2 | 33 | West China HospitalOTHER | 0 | Jan 17, 2025 | clinicaltrials |
| NCT06763315 | Low-dose Selumetinib for the Treatment of Plexiform Neurofibromas in Chinese Children(LS-NF1PNs) | not yet recruiting | Phase 2 | 50 | West China HospitalOTHER | 1 | Jan 8, 2025 | clinicaltrials |
| NCT06741982 | A Clinical Study on Neoadjuvant Treatment of Resectable Head and Neck Squamous Carcinoma With Immune-targeted Therapy and Lysogenic HSV Virus | recruiting | Phase 1 | 21 | West China HospitalOTHER | 1 | Dec 19, 2024 | clinicaltrials |
| NCT06742424 | PD-L1 Antibody + Bevacizumab With Hepatic Arterial Infusion Chemotherapy for Advanced HCC | recruiting | Phase 2 | 36 | West China HospitalOTHER | 1 | Dec 19, 2024 | clinicaltrials |
| NCT06242418 | CtDNA in Adjuvant Chemotherapy of Stage III Colon Cancer (REVISE Trial)(REVISE) | recruiting | Phase 2 | 60 | West China HospitalOTHER | 1 | Dec 12, 2024 | clinicaltrials |
| NCT06482086 | Efficacy of Organoid-Based Drug Screening to Guide Treatment for Locally Advanced Thyroid Cancer | recruiting | Phase 2 | 75 | West China HospitalOTHER | 1 | Dec 5, 2024 | clinicaltrials |
| NCT06713057 | Efficacy of Organoid-Based Chemotherapy Drug Precision Screening to Guide Treatment for Thyroid Cancer | not yet recruiting | Phase 2 | 20 | West China HospitalOTHER | 1 | Dec 3, 2024 | clinicaltrials |
| NCT06290739 | A Machine-learning Model to Predict Lymph Node Metastasis of Intrahepatic Cholangiocarcinoma | completed | — | 483 | West China HospitalOTHER | 1 | Nov 22, 2024 | clinicaltrials |
| NCT06667050 | CAPOX Plus Sintilimab and Bevacizumab Biosimilar (IBI305) for Neoadjuvant Treatment of Locally Advanced Gastric Cancer | active not recruiting | Phase 2 | 58 | West China HospitalOTHER | 1 | Oct 31, 2024 | clinicaltrials |
| NCT06664996 | Sintilimab Combined SBRT As Neoadjuvant Therapy for Resectable HCC with PVTT | recruiting | Phase 2 | 33 | West China HospitalOTHER | 1 | Oct 30, 2024 | clinicaltrials |
| NCT06603805 | Optimal Surgical Approach for Early-Stage Breast Cancer in Chinese Patients Aged ≤ 40 Years: a Cohort Study | completed | — | 974 | West China HospitalOTHER | 0 | Sep 19, 2024 | clinicaltrials |
| NCT06341296 | Phase II Study of Irinotecan Liposomes in First-line Treatment of Metastatic Colorectal Cancer | recruiting | Phase 2 | 86 | West China HospitalOTHER | 1 | Aug 12, 2024 | clinicaltrials |
| NCT06341309 | Exploratory Study of Irinotecan Liposomes in Maintenance Therapy of Metastatic Colorectal Cancer | unknown | Phase 1 / Phase 2 | 20 | West China HospitalOTHER | 0 | Aug 9, 2024 | clinicaltrials |
| NCT06545630 | Tumor Antigen-sensitized DC Vaccine for Colorectal Cancer Liver Metastases | unknown | Phase 1 | 10 | West China HospitalOTHER | 1 | Aug 9, 2024 | clinicaltrials |
| NCT04636008 | Sintilimab Plus Hypofractionated Radiotherapy for MSI-H/dMMR Rectal Cancer | unknown | Phase 1 / Phase 2 | 20 | West China HospitalOTHER | 1 | Aug 6, 2024 | clinicaltrials |
| NCT04716257 | A Prospective, Multi-center, Real-world Study of Ovarian Metastatic Colorectal Cancer Patients(proOMCRC) | unknown | — | 400 | West China HospitalOTHER | 1 | Aug 6, 2024 | clinicaltrials |
| NCT06109207 | Neoadjuvant Camrelizumab With Dalpiciclib for Resectable Head and Neck Squamous Cell Carcinomas | unknown | Phase 1 | 6 | West China HospitalOTHER | 1 | Jul 23, 2024 | clinicaltrials |
| NCT04318730 | Phase II Study for Combination of Camrelizumab and Apatinib in the Second-line Treatment of Recurrent or Metastatic Adrenocortical Carcinoma | unknown | Phase 2 | 21 | West China HospitalOTHER | 1 | Jul 17, 2024 | clinicaltrials |
| NCT06341270 | Efficacy of TEAS on Postoperative Pain and Recovery in Patients Undergoing Hepatectomy | recruiting | N/A | 524 | West China HospitalOTHER | 1 | Jul 15, 2024 | clinicaltrials |
| NCT06439316 | Physical Function and Mental Health in Cancer Survivors | completed | — | 2,932 | West China HospitalOTHER | 0 | Jun 3, 2024 | clinicaltrials |
| NCT06426654 | Sintilimab Combined With LDRT for Neoadjuvant Treatment of Locally Advanced dMMR/MSI-H Gastric Cancer | not yet recruiting | Phase 1 / Phase 2 | 45 | West China HospitalOTHER | 0 | May 23, 2024 | clinicaltrials |
| NCT03712969 | Shenlingcao Oral Liquid for Patients With Stage II or IIIA NSCLC | completed | Phase 4 | 527 | West China HospitalOTHER | 1 | May 9, 2024 | clinicaltrials |
| NCT06406244 | Efficacy of TEAS on Chronic Pain and Survival in Patients Undergoing Hepatectomy | recruiting | N/A | 524 | West China HospitalOTHER | 1 | May 9, 2024 | clinicaltrials |
| NCT06405776 | Effect of Lidocaine on Postoperative Pain and Long-term Survival in Elderly Patients Undergoing Colorectal Surgery | recruiting | N/A | 276 | West China HospitalOTHER | 1 | May 8, 2024 | clinicaltrials |
| NCT06398782 | Prognostic Effect of Body Composition in Cancer Survivors | completed | — | 1,500 | West China HospitalOTHER | 0 | May 3, 2024 | clinicaltrials |
| NCT06394427 | Neoadjuvant Chemoimmunotherapy in Stage IIIA- N2IIIB Non-small Cell Lung Cancer | unknown | — | 250 | West China HospitalOTHER | 0 | May 1, 2024 | clinicaltrials |
| NCT06006026 | The Safety of Ropivacaine TAP Block Combined With Intravenous Lidocaine in Patients Undergoing Colorectal Cancer Surgery | unknown | N/A | 9 | West China HospitalOTHER | 1 | Apr 18, 2024 | clinicaltrials |
| NCT06373133 | SHR-8068 Combined With Adbelizumab and BP102 in the Treatment of Advanced Colorectal Cancer | not yet recruiting | Phase 1 / Phase 2 | 36 | West China HospitalOTHER | 0 | Apr 18, 2024 | clinicaltrials |
| NCT06366308 | Decade-Long Insights Into Transperineal Prostate Biopsy in a West China Population | unknown | — | 10,000 | West China HospitalOTHER | 0 | Apr 16, 2024 | clinicaltrials |
| NCT04387500 | Sintilimab Injection Combined With Inlyta in Fumarate Hydratase- Deficient Renal Cell Carcinoma | unknown | Phase 2 | 41 | West China HospitalOTHER | 1 | Apr 9, 2024 | clinicaltrials |
| NCT06349967 | Nab-paclitaxel Combined With Cadonilimab (AK104) for the Second-line Treatment of Advanced Gastric Cancer | not yet recruiting | Phase 2 | 59 | West China HospitalOTHER | 0 | Apr 5, 2024 | clinicaltrials |
| NCT06350214 | Physical Activity and Nutrition in Cancer Survivors | completed | — | 3,100 | West China HospitalOTHER | 0 | Apr 5, 2024 | clinicaltrials |
| NCT06327594 | Assessment System of Sarcopenia in Lung Cancer Patients | recruiting | — | 1,500 | West China HospitalOTHER | 1 | Mar 25, 2024 | clinicaltrials |
| NCT06323135 | Nutrition Assessment in Advanced Cancer Patients | completed | — | 2,115 | West China HospitalOTHER | 1 | Mar 21, 2024 | clinicaltrials |
| NCT05412576 | a Pilot Study of Lidocaine Infusion for Postoperative Analgesia in Elderly Patients With Colorectal Cancer Surgery | completed | N/A | 220 | West China HospitalOTHER | 1 | Mar 13, 2024 | clinicaltrials |
| NCT05022030 | First-line mCapOX+Cetuximab vs. mFOLFOX6+Cetuximab for Metastatic Left-sided CRC With Wild-type RAS/BRAF Genes(CAPCET) | unknown | Phase 2 | 150 | West China HospitalOTHER | 1 | Mar 7, 2024 | clinicaltrials |
| NCT06225921 | Neoadjuvant Adebrelimab With Dalpiciclib for Resectable Esophageal Squamous Cell Carcinomas | unknown | Phase 1 | 6 | West China HospitalOTHER | 1 | Mar 6, 2024 | clinicaltrials |
| NCT06272617 | Acupuncture for Prevention and Treatment of Oral-related Complications Caused by Radiotherapy for Head and Neck Cancer | unknown | N/A | 138 | West China HospitalOTHER | 1 | Feb 22, 2024 | clinicaltrials |
| NCT06266871 | SOX Combined With Tislelizumab and LDRT for Neoadjuvant Treatment of Locally Advanced Gastric Cancer | unknown | Phase 1 / Phase 2 | 64 | West China HospitalOTHER | 0 | Feb 20, 2024 | clinicaltrials |
| NCT06257719 | Clinical Characteristics of Lymphatic Malformations | completed | — | 320 | West China HospitalOTHER | 1 | Feb 14, 2024 | clinicaltrials |
| NCT05918224 | Streptococcus Salivarius K12 for Prevention and Treatment of Oral Mucositis in Patients Undergoing Radiotherapy | completed | Phase 2 | 160 | West China HospitalOTHER | 1 | Feb 5, 2024 | clinicaltrials |
| NCT03331744 | Clinical Characteristics of Infantile Hemangioma | unknown | — | 1,000 | West China HospitalOTHER | 1 | Jan 24, 2024 | clinicaltrials |
| NCT05324384 | Different Doses of Sirolimus for the Maintenance Treatment of Kaposiform Hemangioendothelioma | unknown | Phase 2 | 30 | West China HospitalOTHER | 1 | Jan 24, 2024 | clinicaltrials |
| NCT06219096 | Application of ICG@HSA Complexes in Fluorescence Image-Guided Laparoscopic Anatomical Liver Resection | recruiting | N/A | 100 | West China HospitalOTHER | 1 | Jan 23, 2024 | clinicaltrials |
| NCT06200363 | A Clinical Study of T3011 in Combination With Regorafenib in Patients With Advanced Colorectal Cancer | unknown | Phase 1 | 15 | West China HospitalOTHER | 1 | Jan 11, 2024 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials